来自牛奶蛋白质的生物活性具有抗氧化,抗炎和抗高血压活性
Thaís Borges1, Pedro Coelho2,3, Cristina Prudêncio2,3
1LAQV-REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre, S/N, 4169-007 Porto, Portugal.
Foods (Basel, Switzerland)
|February 13, 2025
概括
来自乳酸的生物活性被合成并测试了健康益处. 牛乳酸显示出强烈的抗氧化和抗炎作用,而人类乳酸具有最佳的抗高血压活性和最低的毒性.
科学领域:
- 食品科学 食品科学 食品科学
- 生物化学 生物化学
- 营养保健品 营养保健品
背景情况:
- 蛋白质衍生具有有益于健康的多种生物活动.
- 可持续的功能性成分对于物食创新至关重要,与"一健康"原则保持一致.
- 乳酸铁素因其潜在的促进健康的特性而受到探索.
研究的目的:
- 合成和评估来自哺乳动物乳酸的生物活性.
- 研究这些的抗氧化,抗炎和抗高血压活性.
- 为了评估合成的乳酸铁衍生的细胞毒性.
主要方法:
- 化学合成 (自下而上的方法) 用于生产乳酸衍生.
- 使用光谱方法分析的活性.
- 量化了抗氧化,抗炎和抗高血压活动.
主要成果:
- 牛乳酸衍生显示出强大的抗氧化和抗炎性质.
- 人类乳酸衍生显示出显著的抗高血压作用.
- 该研究确定了具有有益健康活动和低细胞毒性组合的乳制.
结论:
- 已识别的乳酸铁可以作为物健康的营养药物.
- 进一步的体内研究是有必要的,以表征的特性和药理动力学.
- 这些发现支持物料新型功能成分的开发.
相关概念视频
Antimicrobial Proteins
875
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
875
Antihypertensive Drugs: Action of Calcium Channel Blockers
443
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
443
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
460
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
460
Antihypertensive Drugs: Action of β1 Blockers
304
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
304
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
43
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374


